6-chloro-2-(1-piperazinyl)pyrazine has been researched along with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in 2 studies
Studies (6-chloro-2-(1-piperazinyl)pyrazine) | Trials (6-chloro-2-(1-piperazinyl)pyrazine) | Recent Studies (post-2010) (6-chloro-2-(1-piperazinyl)pyrazine) | Studies (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) | Trials (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) | Recent Studies (post-2010) (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) |
---|---|---|---|---|---|
157 | 8 | 24 | 755 | 2 | 65 |
Protein | Taxonomy | 6-chloro-2-(1-piperazinyl)pyrazine (IC50) | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1139 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1139 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1139 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1139 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1139 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1139 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1139 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kindler, S; Zohar, J | 1 |
Appleyard, SM; Cui, RJ; Roberts, BL; Zhao, H; Zhu, M | 1 |
1 trial(s) available for 6-chloro-2-(1-piperazinyl)pyrazine and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Article | Year |
---|---|
Update of the serotonergic hypothesis of obsessive compulsive disorder.
Topics: Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Piperazines; Pyrazines; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin Antagonists | 1992 |
1 other study(ies) available for 6-chloro-2-(1-piperazinyl)pyrazine and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Article | Year |
---|---|
Serotonin activates catecholamine neurons in the solitary tract nucleus by increasing spontaneous glutamate inputs.
Topics: Action Potentials; Animals; Catecholamines; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Glutamic Acid; Male; Mice; Neurons; Patch-Clamp Techniques; Piperazines; Pyrazines; Quinoxalines; Receptors, Presynaptic; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Receptor Agonists; Solitary Nucleus; Tyrosine 3-Monooxygenase | 2012 |